Clinical Trials
> Head and Neck Cancer

CETUXIMAB

A Phase III study of post-operative radiation (IMRT) with and without Cetuximab for locally-advanced resected head and neck cancer.

EMR 100070-001

A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0010718C in subjects with metastatic or locally Multiple/All Tumor Types and expansion to selected indications